Table 1.
Disease | N | % Response |
|||
---|---|---|---|---|---|
Cytogenetic response |
|||||
CHR | Major | Complete | Overall survival | ||
CML chronic | 321 | 77 | 57 | 41 | 91% (18 months) |
CML accelerated | 136 | 26 | 31 | 19 | 81% (12 months) |
CML blastic | 136 | 11 | 40 | 29 | 42% (12 months) |
Abbreviations: CHR, complete hematologic response; CML, chronic myeloid leukemia; ALL, acute lymphoid leukemia; Ph, Philadelphia chromosome.